115 related articles for article (PubMed ID: 38010939)
1. A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson's disease.
Han H; Zhao D; Fang X; Yang W; Wang M; Liu Q; Wang L; Ji Z; Zhang J; Hou Z; Hua L; Wang Y; Wu L
Expert Rev Vaccines; 2023; 22(1):1185-1195. PubMed ID: 38010939
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of clinical rating scales in Wilson's disease.
Volpert HM; Pfeiffenberger J; Gröner JB; Stremmel W; Gotthardt DN; Schäfer M; Weiss KH; Weiler M
BMC Neurol; 2017 Jul; 17(1):140. PubMed ID: 28732478
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.
Cao Z; Zhang C; Zhao S; Sheng Z; Xiang X; Li R; Qian Z; Wang Y; Chen B; Li Z; Liu Y; An B; Zhou H; Cai W; Wang H; Gui H; Xin H; Xie Q
Infect Dis Poverty; 2022 May; 11(1):56. PubMed ID: 35578350
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography as a marker of neurodegeneration in patients with Wilson's disease.
Langwińska-Wośko E; Litwin T; Dzieżyc K; Karlinski M; Członkowska A
Acta Neurol Belg; 2017 Dec; 117(4):867-871. PubMed ID: 28488258
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of neurological Wilson's disease with corpus callosum abnormalities.
Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM
BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
7. Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease.
Ziemssen T; Smolinski L; Członkowska A; Akgun K; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Redzia-Ogrodnik B; Litwin T
Acta Neurol Belg; 2023 Jun; 123(3):917-925. PubMed ID: 36098934
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Yang S; Li Y; Dai L; Wang J; He P; Li C; Fang X; Wang C; Zhao X; Huang E; Wu C; Zhong Z; Wang F; Duan X; Tian S; Wu L; Liu Y; Luo Y; Chen Z; Li F; Li J; Yu X; Ren H; Liu L; Meng S; Yan J; Hu Z; Gao L; Gao GF
Lancet Infect Dis; 2021 Aug; 21(8):1107-1119. PubMed ID: 33773111
[TBL] [Abstract][Full Text] [Related]
9. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
[TBL] [Abstract][Full Text] [Related]
10. Large-scale networks changes in Wilson's disease associated with neuropsychiatric impairments: a resting-state functional magnetic resonance imaging study.
Wang A; Dong T; Wei T; Wu H; Yang Y; Ding Y; Li C; Yang W
BMC Psychiatry; 2023 Nov; 23(1):805. PubMed ID: 37924073
[TBL] [Abstract][Full Text] [Related]
11. Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations.
Rędzia-Ogrodnik B; Członkowska A; Bembenek J; Antos A; Kurkowska-Jastrzębska I; Skowrońska M; Smoliński Ł; Litwin T
Neurol Sci; 2022 Jul; 43(7):4405-4412. PubMed ID: 35275318
[TBL] [Abstract][Full Text] [Related]
12. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Leinweber B; Möller JC; Scherag A; Reuner U; Günther P; Lang CJ; Schmidt HH; Schrader C; Bandmann O; Czlonkowska A; Oertel WH; Hefter H
Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
[TBL] [Abstract][Full Text] [Related]
14. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
[TBL] [Abstract][Full Text] [Related]
15. Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey.
Tang Q; Li F; Tian J; Kang J; He J
Clin Exp Med; 2023 Jun; 23(2):457-463. PubMed ID: 35612692
[TBL] [Abstract][Full Text] [Related]
16. Plasma neurofilament light chain as a biomarker in Wilson's disease.
Yang J; Huang Z; Yang H; Luo Y; You H; Chen D; Pei Z; Li X
Parkinsonism Relat Disord; 2022 Feb; 95():5-10. PubMed ID: 34942565
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
[TBL] [Abstract][Full Text] [Related]
18. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
19. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
